Peripheral kappa opioid receptor activation drives cold hypersensitivity in mice | bioRxiv
Frontiers | The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies
Novel Compound Promising Alternative to Current Opioids
Design of a Stable Cyclic Peptide Analgesic Derived from Sunflower Seeds that Targets the κ-Opioid Receptor for the Treatment of Chronic Abdominal Pain | Journal of Medicinal Chemistry
PDF) The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies
Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects
Will peripherally restricted kappa‐opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential? - Albert‐Vartanian - 2016 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
Cara Therapeutics: Scratching An Itch Left Unscratched (NASDAQ:CARA) | Seeking Alpha
Strategies for Developing κ Opioid Receptor Agonists for the Treatment of Pain with Fewer Side Effects | Journal of Pharmacology and Experimental Therapeutics
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
Kappa opioid receptor binding affinity and the effects on... | Download Scientific Diagram
Frontiers | Advances in Achieving Opioid Analgesia Without Side Effects
Open AccessJournals | List of Open Access Journals | Juniper Publishers
Pharmaceuticals | Free Full-Text | Therapeutic Potential of Kappa Opioid Agonists
Cara Therapeutics: Scratching An Itch Left Unscratched (NASDAQ:CARA) | Seeking Alpha
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
Kappa Opioid Receptor Ligands and Pharmacology: Diphenethylamines, a Class of Structurally Distinct, Selective Kappa Opioid Ligands | SpringerLink
5 Promising Companies In The Non-Opioid Drug Industry | Avise Analytics
SEC Filing | Cara Therapeutics
Will peripherally restricted kappa‐opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential? - Albert‐Vartanian - 2016 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
Peptide Kappa Opioid Receptor Ligands and Their Potential for Drug Development | SpringerLink
PDF) Targeting Peripheral Kappa Opioid Receptors for the Treatment of Chronic Pain: Review Article
